Related Experiment Video

Updated: Jun 13, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

[Analysis for clinical features of cardiovascular complication of diffuse connective tissue disease]

Xiao-li Deng1, Xiang-yuan Liu, Jin-xia Zhao

  • 1Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.

Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences
|April 17, 2010
PubMed

Insights

Cardiovascular complications are common in diffuse connective tissue diseases (dCTD), particularly rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). These conditions, including hypertension and coronary artery disease, lead to a poor prognosis, with SLE patients experiencing earlier onset.

Area of Science:

  • Cardiology
  • Rheumatology
  • Internal Medicine

Context:

  • Diffuse connective tissue diseases (dCTD) significantly increase the risk of cardiovascular complications.
  • Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are the most prevalent dCTDs associated with cardiovascular disease requiring hospitalization.

Purpose:

  • To investigate the clinical features and prognosis of cardiovascular complications in patients with dCTD.
  • To compare cardiovascular disease manifestations between RA and SLE subsets within the dCTD cohort.

Summary:

  • Hypertension, hyperlipidemia, and coronary artery disease are the most frequent cardiovascular complications in dCTD patients.
  • Common echocardiographic findings include valvular regurgitation, diastolic dysfunction, left atrial enlargement, pulmonary hypertension, and pericardial effusion.
  • SLE patients exhibit a younger age of onset for hypertension, coronary artery disease, and hyperlipidemia compared to RA patients.

Impact:

  • The study highlights the poor prognosis for dCTD patients with cardiovascular complications.
  • Early onset of cardiovascular diseases in SLE patients underscores the need for tailored monitoring and management strategies.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...